Javed Anees/LinkedIn
Jun 18, 2026, 02:07
Javed Anees: ATA 2026 Guidelines – A New Era in Thyroid Care During Pregnancy
Javed Anees, Medical Consultant at Government of Kerala, shared a post on LinkedIn:
“ATA 2026 Guidelines: A New Era in Thyroid Care During Pregnancy
The American Thyroid Association (ATA) 2026 Guidelines introduce important updates in the management of thyroid disease during preconception, pregnancy, and postpartum care.
- The traditional universal TSH 2.5 mIU/L first-trimester cutoff is no longer recommended
- Greater emphasis on trimester-specific, population-specific, and laboratory-specific reference ranges
- TSH >4.0 mIU/L is generally considered abnormal when pregnancy-specific ranges are unavailable
- All overt hypothyroidism should be treated with levothyroxine
- Women already receiving levothyroxine should increase the dose by approximately 20–30% once pregnancy is confirmed
- Routine levothyroxine is not recommended for euthyroid, TPO-antibody–positive women with infertility
- New focus on avoiding overtreatment, individualized care, and shared decision-making
- Updated guidance on Graves disease, antithyroid drug selection, postpartum thyroiditis, and postpartum dose adjustment
The central message is clear: precision medicine has replaced one-size-fits-all thyroid management in pregnancy.
Understanding these updates is essential for physicians involved in Internal Medicine, Endocrinology, Obstetrics, Family Medicine, and Maternal–Fetal Medicine.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
ATA 2026 Guidelines
Endocrinology
Family Medicine
Fertility
Fertility News
Graves disease
hypothyroidism
individualized care
infertility
Internal medicine
Javed Anees
laboratory-specific
Levothyroxine
Maternal Fetal Medicine
Obstetrics
population-specific
postpartum thyroiditis
pregnancy
reproductive health
Reproductive Medicine
The American Thyroid Association (ATA)
Thyroid Care
TPO-antibody–positive
trimester-specific
TSH
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic
